Elevated IGF2BP1 expression has been implicated in the development and progression of various cancers in, e.g., ovary, lung, pancreas, liver and breast and is typically associated with poor prognosis [24,25,26,27,28,29]. The gene discussed is IGF2BP1; the disease is cancer.